Life,
Год журнала:
2023,
Номер
13(10), С. 2023 - 2023
Опубликована: Окт. 8, 2023
The
human
gut
microbiota
(GM)
is
a
complex
microbial
ecosystem
that
colonises
the
gastrointestinal
tract
(GIT)
and
comprised
of
bacteria,
viruses,
fungi,
protozoa.
GM
has
symbiotic
relationship
with
its
host
fundamental
for
body
homeostasis.
not
limited
to
scope
GIT,
but
there
are
bidirectional
interactions
between
other
organs,
highlighting
concept
"gut-organ
axis".
Any
deviation
from
normal
composition
GM,
termed
"microbial
dysbiosis",
implicated
in
pathogenesis
various
diseases.
Only
few
studies
have
demonstrated
modifications
disease
phenotypes,
it
still
unknown
whether
an
altered
contributes
or
simply
reflects
status.
Restoration
probiotics
prebiotics
been
postulated,
evidence
effects
limited.
Prebiotics
substrates
"selectively
utilized
by
microorganisms,
conferring
health
benefit".
This
study
highlights
vital
organs
demonstrates
dysbiosis
emergence
certain
representative
Finally,
this
article
focuses
on
potential
as
target
therapy
manipulate
presents
gaps
literature
research.
Molecular Nutrition & Food Research,
Год журнала:
2024,
Номер
68(6)
Опубликована: Фев. 11, 2024
Abstract
The
human
gut
microbiota
regulates
estrogen
metabolism
through
the
“estrobolome,”
collection
of
bacterial
genes
that
encode
enzymes
like
β‐glucuronidases
and
β‐glucosidases.
These
deconjugate
reactivate
estrogen,
influencing
circulating
levels.
estrobolome
mediates
enterohepatic
circulation
bioavailability
estrogen.
Alterations
in
composition
function
have
been
associated
with
estrogen‐related
diseases
breast
cancer,
enometrial
polycystic
ovarian
syndrome
(PCOS).
This
is
likely
due
to
dysregulated
signaling
partly
contributed
by
microbial
impacts
on
metabolism.
Dietary
phytoestrogens
also
undergo
into
active
metabolites
equol,
which
binds
receptors
exhibits
higher
estrogenic
potency
than
its
precursor
daidzein.
However,
ability
produce
equol
varies
across
populations,
depending
presence
specific
microbes.
Characterizing
equol‐producing
populations
can
provide
microbiome‐based
biomarkers.
Further
research
needed
investigate
components
estrobolome,
phytoestrogen‐microbiota
interactions,
mechanisms
linking
dysbiosis
pathology.
current
evidence
suggests
an
integral
regulator
status
clinical
relevance
women's
health
hormonal
disorders.
Objective
Chronic
obstructive
pulmonary
disease
(COPD)
is
a
major
cause
of
global
illness
and
death,
most
commonly
caused
by
cigarette
smoke.
The
mechanisms
pathogenesis
remain
poorly
understood,
limiting
the
development
effective
therapies.
gastrointestinal
microbiome
has
been
implicated
in
chronic
lung
diseases
via
gut-lung
axis,
but
its
role
unclear.
Design
Using
an
vivo
mouse
model
smoke
(CS)-induced
COPD
faecal
microbial
transfer
(FMT),
we
characterised
microbiota
using
metagenomics,
proteomics
metabolomics.
Findings
were
correlated
with
airway
systemic
inflammation,
gut
histopathology
function.
Complex
carbohydrates
assessed
mice
high
resistant
starch
diet,
16
patients
randomised,
double-blind,
placebo-controlled
pilot
study
inulin
supplementation.
Results
FMT
alleviated
hallmark
features
(inflammation,
alveolar
destruction,
impaired
function),
pathology
immune
changes.
Protective
effects
additive
to
smoking
cessation,
CS-associated
after
antibiotic-induced
depletion
was
sufficient
increase
inflammation
while
suppressing
colonic
immunity
absence
CS
exposure.
Disease
relative
abundance
Muribaculaceae,
Desulfovibrionaceae
Lachnospiraceae
family
members.
Proteomics
metabolomics
identified
downregulation
glucose
metabolism
microbiota,
supplementation
or
human
complex
improved
outcomes.
Conclusion
contributes
can
be
targeted
therapeutically.
Abstract
Recent
advances
in
understanding
the
modulatory
functions
of
gut
and
microbiota
on
human
diseases
facilitated
our
focused
attention
contribution
to
pathophysiological
alterations
many
extraintestinal
organs,
including
liver,
heart,
brain,
lungs,
kidneys,
bone,
skin,
reproductive,
endocrine
systems.
In
this
review,
we
applied
“gut–X
axis”
concept
describe
linkages
between
other
organs
discussed
latest
findings
related
axis,”
underlying
mechanisms
potential
clinical
intervention
strategies.
Cardiovascular Research,
Год журнала:
2021,
Номер
118(11), С. 2415 - 2427
Опубликована: Сен. 17, 2021
Recent
preclinical
and
observational
cohort
studies
have
implicated
imbalances
in
gut
microbiota
composition
as
a
contributor
to
atrial
fibrillation
(AF).
The
is
complex
dynamic
ecosystem
containing
trillions
of
microorganisms,
which
produces
bioactive
metabolites
influencing
host
health
disease
development.
In
addition
host-specific
determinants,
lifestyle-related
factors
such
diet
drugs
are
important
determinants
the
composition.
this
review,
we
discuss
evidence
suggesting
potential
bidirectional
association
between
AF
microbiota,
identifying
microbiota-derived
possible
regulators
substrate.
We
summarize
effect
on
development
progression
risk
factors,
including
heart
failure,
hypertension,
obesity,
coronary
artery
disease.
also
anti-arrhythmic
effects
pharmacological
diet-induced
modifications
composition,
may
modulate
prevent
AF.
Finally,
highlight
gaps
knowledge
areas
requiring
future
investigation.
Although
data
supporting
direct
relationship
very
limited
at
present
time,
emerging
clinical
research
dealing
with
mechanistic
interactions
it
lead
new
insights
into
pathophysiology
discovery
novel
therapeutic
targets
for
Journal of Clinical Medicine,
Год журнала:
2021,
Номер
10(13), С. 2889 - 2889
Опубликована: Июнь 29, 2021
Chronic
obstructive
pulmonary
disease
(COPD),
the
frequently
fatal
pathology
of
respiratory
tract,
accounts
for
half
a
billion
cases
globally.
COPD
manifests
via
chronic
inflammatory
response
to
irritants,
tobacco
smoke.
The
progression
from
early
onset
advanced
leads
loss
alveolar
wall,
hypertension,
and
fibrosis
epithelium.
Here,
we
focus
on
epidemiology,
progression,
biomarkers
with
particular
connection
lung
cancer.
Dissecting
cellular
molecular
players
in
disease,
aim
shed
light
role
smoking,
which
is
responsible
or
at
least
more
severe
symptoms
worse
patient
outcomes.
We
summarize
conditions,
as
well
EMT
fibroblasts
establishing
cancer-prone
microenvironment,
i.e.,
soil
'COPD-derived'
highlight
that
major
health
problem
can
be
alleviated
smoking
cessation,
diagnosis,
abandonment
usage
biomass
fuels
global
basis.
Nutrients,
Год журнала:
2021,
Номер
13(5), С. 1716 - 1716
Опубликована: Май 19, 2021
The
gut
microbiota
is
often
mentioned
as
a
“forgotten
organ”
or
“metabolic
organ”,
given
its
profound
impact
on
host
physiology,
metabolism,
immune
function
and
nutrition.
A
healthy
diet
undoubtedly
major
contributor
for
promoting
“good”
microbial
community
that
turns
out
to
be
crucial
fine-tuned
symbiotic
relationship
with
the
host.
Both
microbial-derived
components
produced
metabolites
elicit
activation
of
downstream
cascades
capable
modulate
both
local
systemic
responses.
balance
between
keep
intestinal
barrier
an
optimal
homeostasis,
thus
contributing
prevent
disease
occurrence.
How
dietary
habits
can
and,
ultimately,
immunity
in
health
has
been
subject
intense
study,
especially
regard
metabolic
diseases.
Only
recently,
these
links
have
started
explored
relation
lung
objective
this
review
address
current
knowledge
how
affects
it
acts
function.
As
system
seems
key
player
cross-talk
diet,
lungs,
involved
interactions
are
discussed.
There
nutrients
that,
when
present
our
help
homeostasis
lead
healthier
lifestyle,
even
ameliorating
chronic
Thus,
we
hope
incite
scientific
interest
use
valuable
non-pharmacological
addition
diseases
management.
First,
talk
about
through
better
understanding
following
sections,
which
main
focus
article:
way
impacts
gut–lung
axis
explain
modifiable
factor
influencing
several
Fatty
liver
disease
is
the
most
common
in
world.
Its
connection
with
gut
microbiome
has
been
known
for
at
least
80
y,
but
this
association
remains
mostly
unstudied
general
population
because
of
underdiagnosis
and
small
sample
sizes.
To
address
knowledge
gap,
we
studied
link
between
Liver
Index
(FLI),
a
well-established
proxy
fatty
disease,
composition
representative,
ethnically
homogeneous
6,269
Finnish
participants.
We
based
our
models
on
biometric
covariates
compositions
from
shallow
metagenome
sequencing.
Our
classification
could
discriminate
individuals
high
FLI
(≥60,
indicates
likely
steatosis)
low
(<60)
internal
cross-region
validation,
consisting
30%
data
not
used
model
training,
an
average
AUC
0.75
AUPRC
0.56
(baseline
0.30).
In
addition
to
age
sex,
included
differences
11
microbial
groups
class
Clostridia,
belonging
orders
Lachnospirales
Oscillospirales.
were
also
predictive
group
different
cohort,
258
participants,
0.77
0.51
0.21).
Pathway
analysis
representative
genomes
positively
FLI-associated
taxa
(NCBI)
Clostridium
subclusters
IV
XIVa
indicated
presence
of,
e.g.,
ethanol
fermentation
pathways.
These
results
support
several
findings
smaller
case–control
studies,
such
as
role
endogenous
producers
development
liver.
Frontiers in Microbiology,
Год журнала:
2022,
Номер
13
Опубликована: Апрель 1, 2022
The
exact
pathogenesis
of
chronic
obstructive
pulmonary
disease
(COPD)
remains
largely
unknown.
While
current
management
strategies
are
effective
at
stabilizing
the
or
relief
symptoms,
new
approaches
required
to
target
underlying
process
and
reverse
lung
function
deterioration.
Recent
research
showed
that
pneumonia
bacteria
is
critical
in
progression
gut
microbiome
likely
perturbed
COPD,
which
usually
accompanied
by
a
decreased
intestinal
microbial
diversity
disturbance
immune
system,
contributing
inflammation.
cross-talk
between
microbes
lungs,
termed
as
“gut-lung
axis,”
known
impact
response
homeostasis
airway.
Although
respiratory
microbiota
exhibit
compositional
differences,
similarities
origin
epithelia
both
gastrointestinal
tracts,
anatomical
structure,
early-life
colonization.
Evidence
infection
might
be
prevented,
least
dampened
regulating
ecosystem;
thus,
promising
yet
understudied
area
COPD
nutrition-based
preventive
strategies.
patient
often
deficient
nutrient
such
antioxidant,
vitamins,
fiber
intake.
However,
further
larger-scale
randomized
clinical
trials
(RCTs)
establish
role
these
diet
management.
In
this
review,
we
highlight
important
complex
interaction
on
gut-lung
axis.
Further
into
modification
improvement
interventions
through
diet,
probiotics,
fecal
transplantation
extreme
provide
therapies
for
COPD.
Respiratory Research,
Год журнала:
2022,
Номер
23(1)
Опубликована: Янв. 15, 2022
Chronic
obstructive
pulmonary
disease
(COPD)
is
a
chronic
inflammatory
lung
characterized
by
persistent
limitation
in
airflow.
Gut
microbiota
closely
correlated
with
inflammation.
However,
gut
has
not
been
studied
patients
declining
function,
due
to
progression.Stool
samples
were
obtained
from
55
COPD
that
stable
condition
at
enrolment
(stage
1)
and
1-year
follow-up
2).
After
extracting
stool
DNA,
we
performed
next
generation
sequencing
analyse
the
distribution
of
microbiota.Patients
divided
control
function
groups,
based
on
whether
rate
forced
expiratory
volume
1
s
(FEV1)
had
declined
over
time.
An
alpha
diversity
analysis
initial
showed
significant
difference
community
richness
group,
but
group.
At
phylum
level,
Bacteroidetes
was
more
abundant
group
Firmicutes
The
Alloprevotella
genus
than
follow-up,
mean
proportions
Acinetobacter
Stenotrophomonas
significantly
increased
respectively.Some
shifts
associated
decline
under
regular
treatment.
Future
studies
should
investigate
mechanism
underlying
alterations
changes
bacterial
communities,
COPD.